Intercell Biomedical appoints site director
pharmafile | October 6, 2010 | Appointment | Manufacturing and Production, Research and Development |Â Â Intercell, appointment, research and developmentÂ
Austrian biotech Intercell Biomedical has appointed Eric Frings as site director of its Livingston, Scotland operations.
He joins the firm from Novartis Vaccines, where he held a wide range of positions of increasing responsibility at its Marburg, Germany facility.
Prior to his time with Novartis Eric served at Chiron Vaccines.
Related Content
Charity commits £800,000 to AI research into late breast cancer recurrence
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …
PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …
AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …
